FDA · 新闻稿·2026-10-30 21:16· 18 天前精选AI 评分42Agios 股价因 FDA 延长审评而下跌Agios stock falls on FDA review extension (AGIO:NASDAQ) - Seeking AlphaAI 导读据 Seeking Alpha 报道,Agios(AGIO:NASDAQ)股价因 FDA 延长审评而下跌。材料仅提供标题摘要,未披露具体药品、审评事项及延长期限。来源:FDA · 新闻稿 · news.google.com#审批/上市#国际动态查看事件全部后续